Inductive Quotient

Inductive Quotient (IQA) is a full-service contract research organization (CRO) that combines clinical development expertise with AI-powered platforms to support sponsors and CROs across the full clinical trial lifecycle. The company delivers end-to-end services spanning pre-clinical through Phase IV studies, real-world evidence, health economics, medical devices, genomics, and life sciences data and digital services, operating under globally recognized quality and compliance standards including ISO 27001, HIPAA, and GDPR.

IQA positions itself as a single accountable partner offering both full-service outsourcing and flexible engagement models, with a delivery track record of over 300 clinical trials (Phase I–IV), more than 700 bioavailability and bioequivalence studies, 25 or more medical device studies, and over 10 preclinical programs. The company also maintains quantum-safe security capabilities through a strategic partnership.

Service Areas

• Clinical and Preclinical Development: End-to-end support from study planning and execution through regulatory-ready data, analysis, and submission support across clinical and preclinical programs.
• Medical Devices and SaMD: Regulatory, clinical, and post-market support for medical devices, diagnostics, and software as a medical device across global markets.
• Genomics and Biomarkers: Scientific and data-driven support for biomarker strategy, translational programs, genomics workflows, and discovery-stage decision-making.
• Market Access, RWE, and HEOR: Evidence generation, real-world data management, and health economics support to strengthen market access, value demonstration, and post-market insight.
• Healthcare and HealthTech: Digital health, healthcare analytics, workflow optimization, and interoperability services supporting modern care delivery and connected health ecosystems.
• Life Sciences Data, Digital, and IT Services: End-to-end data, digital, and IT services helping organizations connect data, modernize applications, support platforms, and enable analytics, AI, and regulated execution.

Proprietary Clinical Platforms

• InductiveEDC: A metadata-driven electronic data capture platform designed to support faster study build, cleaner data capture, stronger oversight, and more efficient downstream execution across clinical research programs.
• Prabandhan: A unified project oversight and meta-analysis solution that consolidates study operations, milestones, vendor management, compliance tracking, financial tracking, and cross-study visibility in a single connected environment.
• TrialLattice: A collaborative platform designed to streamline study start-up, strengthen site and stakeholder coordination, and connect workflows across study teams and partners.
• ClinEvra: A metadata-driven end-to-end workflow orchestration solution that dynamically extracts study assets from protocols and transforms them into structured, downstream-ready outputs for database build, validation, trial domains, SDTM preparation, and regulated study execution.

Engagement Models

• Full Service Outsourcing: Complete outsourcing of clinical trials from startup to closeout, with IQA taking full delivery responsibility. Available on fixed-price or unit-based terms with an outcome-focused approach.
• FSP and Embedded Teams: Dedicated resources that integrate into a client's existing teams and systems, offering resource flexibility, process control, and scalable capacity.
• GCC Enablement (Build-Operate-Transfer): IQA builds, operates, and transfers a dedicated capability center for the client in India, providing cost arbitrage, talent ownership, and strategic control.

Therapeutic and Product Experience

• Therapeutic areas: Oncology, ophthalmology, dermatology, gastroenterology, neurology, cardiovascular, haematology, urology, and rare diseases.
• Product types: New chemical entities (NCEs), generics, biosimilars, vaccines, medical devices, and digital health solutions.
• Regulatory experience aligned to global regulatory expectations across clinical, device, data, and evidence-driven programs.

Quality and Compliance

• Operates under globally recognized standards and certifications to ensure data integrity and regulatory compliance.
• Applies Quality by Design and Risk-Based Quality Management (RBQM) principles across programs.
• Provides real-time visibility and full traceability across study execution.
• Enterprise-grade security infrastructure audited to ISO 27001, and compliant with HIPAA and GDPR requirements.
• Quantum-safe security capabilities available through a strategic partnership.

IQA serves both sponsors and CROs seeking a partner that combines clinical operations expertise with purpose-built technology platforms, offering flexible commercial structures and delivery models suited to organizations at varying stages of clinical development maturity.